Therapeutic drug monitoring of caffeine and its primary metabolites in plasma using LC–ESI–MS/MS for apnea of prematurity treatment: Evaluation of ultrapure water as a surrogate matrix-Reference-Cited by-同舟云学术

Therapeutic drug monitoring of caffeine and its primary metabolites in plasma using LC–ESI–MS/MS for apnea of prematurity treatment: Evaluation of ultrapure water as a surrogate matrix

Published:2022-08-09 Issue:11 Volume:36 Page:
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Long Jia‐Yi¹²^ORCID,Hu Ya‐Hui¹^ORCID,Xia Ying¹,Du Fei‐Fei³,Dai Hao‐Ran²^ORCID,Tian Man¹,Xu Jing¹,Cheng Rui⁴,Ding Xuan‐Sheng²,Guo Hong‐Li¹^ORCID,Chen Feng¹^ORCID

Affiliation:

1. Pharmaceutical Sciences Research Center, Department of Pharmacy Children's Hospital of Nanjing Medical University Nanjing China

2. School of Basic Medicine and Clinical Pharmacy China Pharmaceutical University Nanjing China

3. State Key Laboratory of Drug Research Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai China

4. Neonatal Intensive Care Unit Children's Hospital of Nanjing Medical University Nanjing China

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bmc.5462

Reference39 articles.

1. Validated HPLC Method for Determination of Caffeine Level in Human Plasma using Synthetic Plasma: Application to Bioavailability Studies

2. Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns

3. Sex-based differences in apnoea of prematurity: A retrospective cohort study

4. Effects of caffeine and theophylline on adenosine and benzodiazepine receptors in human brain

5. DBS–LC–MS/MS assay for caffeine: validation and neonatal application

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A small step toward precision dosing of caffeine in preterm infants: An external evaluation of published population pharmacokinetic models;European Journal of Pharmaceutics and Biopharmaceutics;2024-11

2. Farmakoterapia bezdechu u wcześniaczej subpopulacji neonatologicznej– możliwości terapeutyczne, implikacje farmakokinetyczne i wskazania do terapeutycznego monitorowania stężeniem leku we krwi;Prospects in Pharmaceutical Sciences;2024-05-08

3. Quantification of Melatonin, Caffeine, and Paraxanthine in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry;Chromatographia;2024-01-17

4. From “wet” matrices to “dry” blood spot sampling strategy: a versatile LC-MS/MS assay for simultaneous monitoring caffeine and its three primary metabolites in preterm infants;Clinical Chemistry and Laboratory Medicine (CCLM);2023-07-13

5. Efficacy and Safety Evaluation of Different Maintenance Dose Regimens of Caffeine Citrate in the Treatment of Primary Apnea in Preterm Infants;CURRENT TOPICS IN NUTRACEUTICAL RESEARCH;2023-07-07